Metformina Pensa

Metformin, the active ingredient in Metformina Pensa, is a biguanide presented as an unknown/unknown for oral use. It reduces hepatic glucose production and improves insulin sensitivity, treating type 2 diabetes mellitus in adult patients. It is commonly prescribed as part of a comprehensive diabetes management plan, often combined with diet and exercise modifications.

GNH USA supplies Metformina Pensa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Metformina Pensa (metformin) acts on glucose metabolism pathways to improve glycemic control in diabetes.

Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. Prediabetes (impaired glucose tolerance): helps delay progression to type 2 diabetes. Polycystic ovary syndrome: may improve insulin resistance and restore ovulatory function.

Metformina Pensa may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhea: loose stools, often transient. - Metallic taste: altered taste perception.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Vitamin B12 deficiency: long‑term use may reduce B12 absorption.

When prescribing Metformina Pensa, clinicians should consider several safety precautions to minimise risk. - Renal function: assess creatinine clearance before initiation and monitor periodically. - Hepatic disease: use with caution in patients with liver impairment. - Alcohol consumption: avoid excessive intake due to increased lactic acidosis risk. - Pregnancy and lactation: evaluate risk‑benefit; use only if clearly needed. - Elderly patients: consider dose reduction and monitor for accumulation. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformina Pensa can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure when combined. - Cimetidine: can increase metformin plasma concentrations. - Alcohol: excessive use heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycaemia. - Diuretics (thiazides): can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes.